Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy

被引：7
|
作者：
Sumanaru, Dorin [1 ]
Josseran, Loic [2 ,3 ]
Essid, Aben [1 ]
Mbieleu, Blaise [1 ]
Haegy, Isabelle [1 ]
Bergounioux, Jean [1 ,2 ,4 ]
机构：
[1] Hop Raymond Poincare, AP HP, Pediat Intens Care Unit, F-92380 Garches, France
[2] Hop Raymond Poincare, AP HP, Epidemiol Dept, F-92380 Garches, France
[3] Versailles St Quentin Yvelines Univ, Versailles, France
[4] Hop Raymond Poincare, AP HP, Reanimat & Soins Intensifs Pediat, 104 Blvd Raymond Poincare, F-92380 Garches, France
来源：
PEDIATRIC CARDIOLOGY | 2019年 / 40卷 / 03期
关键词：
Duchenne muscular dystrophy; Levosimendan; Acute heart failure; ARRHYTHMIAS; SAFETY;
D O I：
10.1007/s00246-019-02072-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The longer survival of patients with Duchenne muscular dystrophy due to advances in clinical care has increased the incidence of Duchenne muscular dystrophy-associated cardiomyopathy, a nearly consistent feature in the third decade of life. A 26-year-old patient with Duchenne muscular dystrophy experienced severe acute heart failure triggered by pneumonia. Levosimendan was effective in improving heart function.
引用
收藏
页码：668 / 670
页数：3
相关论文
共 50 条
  • [31] Levosimendan as rescue therapy in acute primary organ failure after heart transplantation [Levosimendan als rescue-therapie bei akutem primären transplantatversagen nach herztransplantation]
    Weis F.
    Beiras-Fernandez A.
    Kaczmarek I.
    Kur F.
    Hauer D.
    Schmoeckel M.
    Reichart B.
    Weis M.
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2007, 21 (6) : 280 - 283
  • [32] Retroviral vectors for gene therapy of Duchenne muscular dystrophy
    Fassati, A
    Bresolin, N
    NEUROLOGICAL SCIENCES, 2000, 21 (05) : S925 - S927
  • [33] Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy
    Garrood, P.
    Eagle, M.
    Jardine, P. E.
    Bushby, K.
    Straub, V.
    NEUROMUSCULAR DISORDERS, 2008, 18 (01) : 71 - 73
  • [34] CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
    Chemello, Francesco
    Olson, Eric N.
    Bassel-Duby, Rhonda
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 379 - 387
  • [35] TRENDS IN STEROID THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY IN JAPAN
    Takeuchi, Fumi
    Komaki, Hirofumi
    Nakamura, Harumasa
    Yonemoto, Naohiro
    Kashiwabara, Kousuke
    Kimura, En
    Takeda, ShiN'Ichi
    MUSCLE & NERVE, 2016, 54 (04) : 673 - 680
  • [36] Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy
    Daniel P. Judge
    David A. Kass
    W. Reid Thompson
    Kathryn R. Wagner
    American Journal of Cardiovascular Drugs, 2011, 11 : 287 - 294
  • [37] CORTICOSTEROID-THERAPY IN DUCHENNE MUSCULAR-DYSTROPHY
    KHAN, MA
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 120 (01) : 8 - 14
  • [38] Vibration Therapy Tolerated in Children With Duchenne Muscular Dystrophy: A Pilot Study
    Myers, Kenneth A.
    Ramage, Barbara
    Khan, Aneal
    Mah, Jean K.
    PEDIATRIC NEUROLOGY, 2014, 51 (01) : 126 - 129
  • [39] Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy
    Odom, Guy L.
    Banks, Glen B.
    Schultz, Brian R.
    Gregorevic, Paul
    Chamberlain, Jeffrey S.
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (09) : 1149 - 1157
  • [40] Duchenne muscular dystrophy gene therapy: Lost in translation?
    Duan, Dongsheng
    RESEARCH AND REPORTS IN BIOLOGY, 2011, 2 : 31 - 42
12345